Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | GGT1 | P19440 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | ARG1 | P05089 | 2/20 | 0.32 |
| ▸ | ARG2 | P78540 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.32 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29489674 | 1.00 | ALDH1A1 (0.34) | ALDH1A1CYP1A2GGT1MEN1THRB | |
| SCHEMBL574079 | 1.00 | ALDH1A1 (0.34) | ALDH1A1CYP1A2GGT1MEN1THRB | |
| SCHEMBL22636108 | 1.00 | ALDH1A1 (0.34) | ALDH1A1CYP1A2GGT1MEN1THRB | |
| SCHEMBL202556 | 1.00 | ALDH1A1 (0.34) | ALDH1A1CYP1A2GGT1MEN1THRB | |
| SCHEMBL20854287 | 1.00 | ALDH1A1 (0.34) | ALDH1A1CYP1A2GGT1MEN1THRB | |
| SCHEMBL18274694 | 0.83 | GABRR1 (0.36) | ALDH1A1CYP1A2GGT1TSHRNOS1 | |
| SCHEMBL5322047 | 0.83 | GABRR1 (0.36) | ALDH1A1CYP1A2GGT1TSHRNOS1 | |
| SCHEMBL20854183 | 0.82 | CHRM1 (0.44) | ALDH1A1CYP1A2GGT1MEN1THRB | |
| SCHEMBL20854296 | 0.82 | CHRM1 (0.44) | ALDH1A1CYP1A2GGT1MEN1THRB | |
| SCHEMBL18770575 | 0.81 | CA1 (0.35) | KIF11CA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2085 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250049970-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | MARIANA ONCOLOGY INC (US) | 2025-02-13 | — | — | US | claimed |
| US-20250034210-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | MARIANA ONCOLOGY INC (US) | 2025-01-30 | — | — | US | claimed |
| US-20250011368-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | MARIANA ONCOLOGY INC (US) | 2025-01-09 | — | — | US | claimed |
| US-20160318987-A1 | PROTEASE RESISTANT PEPTIDES | MEDIMMUNE LIMITED (GB) | 2016-11-03 | — | — | US | claimed |
| EP-3080153-A2 | PROTEASE RESISTANT PEPTIDES | Medimmune Limited (GB) | 2016-10-19 | — | — | EP | claimed |
| WO-2015086686-A2 | PROTEASE RESISTANT PEPTIDES | MEDIMMUNE LIMITED (GB) | 2015-06-18 | — | — | WO | claimed |
| US-20090215895-A1 | Therapeutic and carrier molecules | PEPLIN BIOLIPIDS PTY LTD (AU) | 2009-08-27 | — | — | US | claimed |
| EP-1718602-A4 | THERAPEUTIC AND CARRIER MOLECULES | PEPLIN BIOLIPIDS PTY LTD (AU) | 2007-12-12 | — | — | EP | claimed |
| US-7256172-B1 | Method of treatment and agents useful for same | THE UNIVERSITY OF MELBOURNE (AU) | 2007-08-14 | — | — | US | claimed |
| EP-1718602-A1 | THERAPEUTIC AND CARRIER MOLECULES | Peplin Biolipids Pty Ltd. (AU) | 2006-11-08 | — | — | EP | claimed |
| US-7070969-B1 | Plasmin inhibitors from the australian brown snake Pseudonaja textilis textilis | THE UNIVERSITY OF QUEENSLAND (AU) | 2006-07-04 | — | — | US | claimed |
| WO-2005073164-A1 | THERAPEUTIC AND CARRIER MOLECULES | PEPLIN BIOLIPIDS PTY LTD (AU) | 2005-08-11 | — | — | WO | claimed |
| WO-2026107423-A1 | ORAL PEPTIDES AND USES THEREOF FOR WEIGHT LOSS, WEIGHT MAINTENANCE, AND MANAGEMENT OF METABOLIC CONDITIONS | METSERA, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| WO-2026085582-A1 | PROTEIN CAGES | THE UNIVERSITY OF SYDNEY (AU) | 2026-04-30 | — | — | WO | disclosed |
| EP-4727655-A1 | DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF | Mariana Oncology Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260069728-A1 | MULTI-TARGETING COMPOUND AND USE THEREOF | CHENGDU SHETAI MEDICAL TECHNOLOGY CO., LTD. (CN) | 2026-03-12 | — | — | US | disclosed |
| WO-1994003483-A1 | ENDOTHELIN RECEPTOR-BINDING COMPOUNDS | CHIRON CORPORATION (US) | 1994-02-17 | — | — | WO | disclosed |
| EP-0169300-B1 | PROCESS FOR PREPARATION OF ALPHA-ALKYL AMINO ACIDS | MERCK & CO. INC. (US) | 1988-05-25 | — | — | EP | disclosed |
| EP-0169300-A1 | Process for preparation of alpha-alkyl amino acids | MERCK & CO. INC. (US) | 1986-01-29 | — | — | EP | disclosed |
| US-4508921-A | Process for preparation of alpha-alkyl amino acids | MERCK & CO., INC. (US) | 1985-04-02 | — | — | US | disclosed |